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What are they? Rhomboids are a
recently discovered family of serine
proteases that cleave substrates
within transmembrane domains. All
rhomboids have multiple
transmembrane domains (typically
six or seven) and it is proposed that
they work by forming the classical
charge relaying catalytic triad —
famous from serine proteases such
as chymotrypsin — between their
transmembrane domains.
Hang on! Surely proteolysis
can’t work in the hydrophobic
membrane bilayer...? Actually,
the rhomboid family joins an
exclusive club of proteases that
appear to do just that. The
presenilins and signal peptide
peptidase are intramembrane
aspartyl proteases; they cleave
substrates including the Notch
receptor and the amyloid precursor
protein, which is implicated in
Alzheimer’s disease. The site-2
protease family are intramembrane
metalloproteases; among other
things, they regulate cholesterol
biosynthesis. It’s probably no
coincidence that, although these
families are unrelated, they all have
multiple transmembrane domains:
this may produce a hydrophilic
microenvironment around the
active site of hydrolysis.
So all this can actually be seen
in crystal structures? No, it’s
inferred from biochemistry and
genetics. Nobody has yet
succeeded in solving the structure
of any of these proteins. But to be
fair, the evidence for the basic
model is pretty strong.
Why the weird name? Blame the
Drosophilists. Rhomboid’s first
recognition came as a mutant
discovered in the genetic screens
that won Christiane Nüsslein-
Volhard and Eric Wieschaus a
Nobel Prize in 1995. Mutant
Drosophila embryos have
rhomboid-shaped heads.
How were they discovered to be
proteases? Genetics indicated
that Rhomboid-1 in flies — we now
know that Drosophila has seven
rhomboids — is a key activator of
epidermal growth factor (EGF)
receptor signalling, and that it
works in the signal-sending cell.
Subsequent biochemistry and cell
biology showed that Rhomboid-1
cleaves and thereby activates three
membrane-tethered EGF-like
ligands. This occurs in the Golgi
apparatus, where many eukaryotic
rhomboids reside.
Do they all control EGF receptor
signalling? No. For one thing,
rhomboids exist throughout
evolution — from bacteria and
archaea to humans — and most
organisms which have rhomboids
don’t even have receptor tyrosine
kinases, let alone EGF receptors.
But, amazingly, the bacterium
Providencia stuartii uses a
rhomboid to release an intercellular
signalling molecule — a
mechanism apparently analagous
to the activation of EGF ligands by
rhomboids in Drosophila —
implying a common signalling
mechanism between bacteria and
metazoans.
But they all control intercellular
signalling of some kind? No
again. Although we know rather
little about the roles of rhomboids
in most species, they probably do a
wide variety of things — connected
only by the basic mechanism of
releasing a protein from a mem-
brane by proteolysis of its trans-
membrane domain. For example,
eukaryotes all have a mitochondrial
rhomboid that, at least in yeast,
controls membrane fusion by
cleaving a dynamin-like GTPase.
Can rhomboid cleavage sites be
recognised? Not very efficiently,
though current evidence suggests
that all rhomboids recognise, as
well as cleave, transmembrane
domain sequences. There is a
requirement for residues that
destabilise transmembrane α
helices, and substrate
transmembrane domains must
also be relatively hydrophilic near
their luminal end. These
requirements have allowed some
prediction of rhomboid substrates.
What’s the difference between
rhomboids and other
intramembrane proteases?
Apart from the catalytic
mechanism — rhomboids are the
only intramembrane serine
proteases — one important
difference is that all known
rhomboids release extracellular or
luminal domains from
transmembrane domains. The
others all release cytoplasmic
domains, usually tethered
transcription factors. By allowing
intramembrane proteolysis to
occur in the other direction,
rhomboids therefore double the
potential of intramembrane
proteolysis to be a widespread
signalling mechanism.
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Figure 1. A cartoon of a rhomboid (grey)
cutting a substrate within the transmem-
brane domain. The proposed catalytic
triad is highlighted in red.
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